Fund Holdings — Casdin Capital, LLC

Total Portfolio Value:
$1.50B
Total Bought:
$128.21M
Total Sold:
$101.84M
Net Transaction:
+$26.37M
Notable People:
Eli D Casdin, Lawrence Jude Canzoneri, Alexandria Fisk, Angelo Crupi, Steven Michael Giordano
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Biolife Solutions Inc8,707,1658,707,1650$186.59M$218.03M14.54%+$31.43M
Revolution Medicines, Inc.(RVMD)4,406,8754,114,283-292,592$171.03M$186.58M12.44%+$15.55M
GeneDx Holdings Corp.CL A(WGS)3,526,4113,507,164-19,247$92.18M$148.84M9.92%+$56.66M
Standard BioTools Inc.(LAB)63,959,67771,254,677+7,295,000$113.21M$137.52M9.17%+$24.31M
Sarepta Therapeutics, Inc.(SRPT)1,073,5001,073,5000$169.61M$134.07M8.94%-$35.54M
Illumina, Inc.(ILMN)480,000750,000+270,000$50.10M$97.81M6.52%+$47.71M
Avidity Biosciences Inc2,084,8412,084,8410$85.17M$95.76M6.38%+$10.59M
Relay Therapeutics, Inc.(RLAY)8,448,5749,251,108+802,534$55.08M$65.50M4.37%+$10.41M
Alnylam Pharmaceuticals, Inc.(ALNY)170,000170,0000$41.31M$46.76M3.12%+$5.45M
Endeavour Silver Corp.(EXK)650,000650,0000$27.46M$44.28M2.95%+$16.82M
Intellia Therapeutics, Inc.(NTLA)2,000,0002,000,0000$44.76M$41.10M2.74%-$3.66M
Structure Therapeutics IncADS700,000700,0000$27.49M$30.72M2.05%+$3.23M
Blueprint Medicines Corp326,378326,3780$35.18M$30.19M2.01%-$4.99M
Denali Therapeutics Inc.(DNLI)1,300,000990,000-310,000$30.19M$28.84M1.92%-$1.35M
Codexis, Inc.(CDXS)2,000,0008,100,000+6,100,000$6.20M$24.95M1.66%+$18.75M
Veracyte, Inc.(VCYT)857,904666,308-191,596$18.59M$22.68M1.51%+$4.09M
Neurogene Inc.(NGNE)524,616524,6160$19.09M$22.01M1.47%+$2.92M
Verve Therapeutics Inc3,059,0943,995,571+936,477$14.93M$19.34M1.29%+$4.41M
Beam Therapeutics Inc.(BEAM)675,000775,000+100,000$15.82M$18.99M1.27%+$3.17M
Tenaya Therapeutics, Inc.(TNYA)6,732,9716,732,9710$20.87M$12.99M0.87%-$7.88M
4d Molecular Therapeutics In800,0001,150,000+350,000$16.79M$12.43M0.83%-$4.36M
2seventy Bio Inc2,000,0002,000,0000$7.70M$9.44M0.63%+$1.74M
Tango Therapeutics, Inc.(TNGX)1,188,3491,188,3490$10.20M$9.15M0.61%-$1.05M
Syndax Pharmaceuticals, Inc.(SNDX)150,000475,000+325,000$3.08M$9.14M0.61%+$6.06M
Guardant Health, Inc.(GH)100,000350,000+250,000$2.89M$8.03M0.54%+$5.14M
Contineum Therapeutics, Inc.CL A(CTNM)296,666296,6660$5.22M$5.68M0.38%+$453.9K
Century Therapeutics, Inc.(IPSC)5,190,5063,212,316-1,978,190$13.24M$5.49M0.37%-$7.74M
GRAIL, Inc.(GRAL)79,999350,000+270,001$1.23M$4.82M0.32%+$3.59M
Absci Corporation973,260973,2600$3.00M$3.72M0.25%+$720.2K
Pacific Biosciences of California, Inc.(PACB)1,035,8591,035,8590$1.42M$1.76M0.12%+$341.8K
Prime Medicine, Inc.(PRME)367,175367,1750$1.89M$1.42M0.09%-$466.3K
Exscientia PlcADS213,900213,9000$1.09M$1.04M0.07%-$47.1K
Monte Rosa Therapeutics, Inc.(GLUE)261,01486,014-175,000$976.2K$455.9K0.03%-$520.3K
Ginkgo Bioworks Holdings, Inc.CL A(DNA)036,493+36,493$0$297.4K0.02%+$297.4K
Kronos Bio Inc123,839123,8390$153.6K$123.8K0.01%-$29.7K
Ginkgo Bioworks Holdings, Inc.CL A(DNA)1,459,7470-1,459,747$488.0K$0—-$488.0K
Kyverna Therapeutics, Inc.(KYTX)575,0000-575,000$4.31M$0—-$4.31M
Pliant Therapeutics, Inc.(PLRX)1,000,0000-1,000,000$10.75M$0—-$10.75M
Singular Genomics Systems In44,1290-44,129$372.9K$0—-$372.9K
Page 1 of 1
Casdin Capital, LLC — 13F Holdings — Q3 2024 | TickerTrail